News on Glenmark Pharmaceuticals Ltd from BioPortfolio.com http://www.BioPortfolio.com Consolidated Glenmark Pharmaceuticals Ltd news from BioPortfolio.com Wed, 10 Feb 2010 07:18:56 GMT en Reliance Capital drops metal, pharma; picks bankinghttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038147&HITNO=0&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Glenmark%20Pharmaceuticals%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038147&THISHREF=http://c.moreover.com/click/here.pl%3fz2537499288%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038147&HITNO=0&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Glenmark%20Pharmaceuticals%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038147&THISHREF=http://c.moreover.com/click/here.pl%3fz2537499288%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMoneycontrol.com: Glenmark Generics IPO gets CRISIL grade of 4/5http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034669&HITNO=1&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Glenmark%20Pharmaceuticals%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034669&THISHREF=http://c.moreover.com/click/here.pl%3fz2535915490%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034669&HITNO=1&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Glenmark%20Pharmaceuticals%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034669&THISHREF=http://c.moreover.com/click/here.pl%3fz2535915490%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaBiz: Glenmark Pharmaceuticals - Steady growth recoveryhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027828&HITNO=2&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Glenmark%20Pharmaceuticals%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027828&THISHREF=http://c.moreover.com/click/here.pl%3fz2532388176%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027828&HITNO=2&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Glenmark%20Pharmaceuticals%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027828&THISHREF=http://c.moreover.com/click/here.pl%3fz2532388176%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comEquity Bulls: Finally, working quietly, correctly on drug discoveryhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026924&HITNO=3&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Glenmark%20Pharmaceuticals%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026924&THISHREF=http://c.moreover.com/click/here.pl%3fz2531542903%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026924&HITNO=3&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Glenmark%20Pharmaceuticals%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026924&THISHREF=http://c.moreover.com/click/here.pl%3fz2531542903%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comDNA India: No place like home, finds indian pharmahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026898&HITNO=4&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Glenmark%20Pharmaceuticals%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026898&THISHREF=http://c.moreover.com/click/here.pl%3fz2531501730%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026898&HITNO=4&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Glenmark%20Pharmaceuticals%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026898&THISHREF=http://c.moreover.com/click/here.pl%3fz2531501730%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBusiness Standard India: Glenmark Generics gets TA for Trandolapril, Verapamil hydrochloride ER tabshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019267&HITNO=5&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Glenmark%20Pharmaceuticals%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019267&THISHREF=http://c.moreover.com/click/here.pl%3fz2526198630%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019267&HITNO=5&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Glenmark%20Pharmaceuticals%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019267&THISHREF=http://c.moreover.com/click/here.pl%3fz2526198630%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comExpress Pharma: Domestic sales add booster dose to pharmahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4009014&HITNO=6&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Glenmark%20Pharmaceuticals%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4009014&THISHREF=http://c.moreover.com/click/here.pl%3fz2521791514%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4009014&HITNO=6&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Glenmark%20Pharmaceuticals%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4009014&THISHREF=http://c.moreover.com/click/here.pl%3fz2521791514%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! India: `Buy` Glenmark Pharmaceutical, target Rs 325: Sharekhanhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3997128&HITNO=7&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Glenmark%20Pharmaceuticals%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3997128&THISHREF=http://c.moreover.com/click/here.pl%3fz2516573710%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3997128&HITNO=7&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Glenmark%20Pharmaceuticals%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3997128&THISHREF=http://c.moreover.com/click/here.pl%3fz2516573710%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMyIris: GLENMARK PHARMACEUTICALS LTD. - BONDS: UN-AUDITED FINANCIAL RESULTS; MANAGEMENT DISCUSSION & ANALYSIS AND PRESS RELEASE FOR QUARTER 3 ENDED DECEMBER 31, 2009http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3989336&HITNO=8&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Glenmark%20Pharmaceuticals%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3989336&THISHREF=http://c.moreover.com/click/here.pl%3fz2512358921%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3989336&HITNO=8&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Glenmark%20Pharmaceuticals%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3989336&THISHREF=http://c.moreover.com/click/here.pl%3fz2512358921%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFinanzNachrichten.de: GLENMARK PHARMACEUTICALS LTD. - BONDS: UN-AUDITED FINANCIAL RESULTS; MANAGEMENT DISCUSSION & ANALYSIS AND PRESS RELEASE FOR QUARTER 3 ENDED DECEMBER 31, 2009http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3989335&HITNO=9&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Glenmark%20Pharmaceuticals%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3989335&THISHREF=http://c.moreover.com/click/here.pl%3fz2512358852%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3989335&HITNO=9&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Glenmark%20Pharmaceuticals%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3989335&THISHREF=http://c.moreover.com/click/here.pl%3fz2512358852%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFinanzNachrichten.de: `Accumulate` Glenmark Pharma; target Rs 250: Emkayhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3989863&HITNO=10&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Glenmark%20Pharmaceuticals%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3989863&THISHREF=http://c.moreover.com/click/here.pl%3fz2512968212%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3989863&HITNO=10&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Glenmark%20Pharmaceuticals%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3989863&THISHREF=http://c.moreover.com/click/here.pl%3fz2512968212%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMyIris: Glenmark's net up by 16%, EBDITA dips by 14% in Q3http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3987305&HITNO=11&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Glenmark%20Pharmaceuticals%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3987305&THISHREF=http://c.moreover.com/click/here.pl%3fz2509767073%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3987305&HITNO=11&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Glenmark%20Pharmaceuticals%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3987305&THISHREF=http://c.moreover.com/click/here.pl%3fz2509767073%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaBiz: TABLE-Glenmark Pharma Oct-Dec net up 16 pcthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3983868&HITNO=12&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Glenmark%20Pharmaceuticals%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3983868&THISHREF=http://c.moreover.com/click/here.pl%3fz2507920423%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3983868&HITNO=12&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Glenmark%20Pharmaceuticals%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3983868&THISHREF=http://c.moreover.com/click/here.pl%3fz2507920423%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Malaysia: Glenmark Pharma Q3 net rises 15.5 per cent to Rs 94 crhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3983935&HITNO=13&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Glenmark%20Pharmaceuticals%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3983935&THISHREF=http://c.moreover.com/click/here.pl%3fz2507959169%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3983935&HITNO=13&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Glenmark%20Pharmaceuticals%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3983935&THISHREF=http://c.moreover.com/click/here.pl%3fz2507959169%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comEconomictimes: Glenmark Pharma net up 15.5%http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3985547&HITNO=14&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Glenmark%20Pharmaceuticals%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3985547&THISHREF=http://c.moreover.com/click/here.pl%3fz2508660787%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3985547&HITNO=14&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Glenmark%20Pharmaceuticals%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3985547&THISHREF=http://c.moreover.com/click/here.pl%3fz2508660787%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBusiness Standard India: